Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05997056
Title	Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Aadi Bioscience, Inc.
Indications	pulmonary neuroendocrine tumor gastrointestinal neuroendocrine tumor pancreatic endocrine carcinoma
Therapies	Nab-rapamycin
Age Groups:	adult \| senior
Covered Countries	USA